leisure time -WSS

leisure time

author：hotspot 2025-09-29 14:00:18 - browse：1511

Illumina said Monday afternoon that its board of directors had approved a spin-off of its cancer test subsidiary Grail, signaling that a nearly four-year-long, $8 billion saga will finally draw to a close this month.

Shares in the newly independent Grail are expected to be distributed on June 24, Illumina said in a statement. Illumina will retain a 14.5% stake in the company, which will trade under the ticker $GRAL.

It’s the second time Illumina has spun off Grail, which initially began as a unit within the DNA sequencing giant in 2015. Illumina turned it into an independent company the following year but then agreed to reacquire it for $8 billion in September 2020.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Fetal cell organoids grown from amniotic fluid, study finds

WSS

Ancient Greek ideas underpin modern concepts of pregnancy

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Kidney transplant patients stopped immunosuppressants in trial

Explaining an after

The public health thinking behind the CDC’s new Covid guidance

Sarepta Duchenne therapy fails to meet primary endpoint in trial

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Wildfire smoke exposes gaps in outdoor worker protections

$1 billion proposal to grow Boston, Massachusetts biotech

In age of alternative facts, a scholarly course on calling out crap

Biden's 'march

In Memoriam: Notable people who died in 2023

The health care issue Democrats can’t solve: hospital reform

The high cost of giving birth even with insurance

Readout Newsletter: BridgeBio, Akero, and human embryo models

Wikipedia

DeepMind touts AlphaFold's new skills as protein folding AI models face off

The public health thinking behind the CDC’s new Covid guidance

Prime Medicine says its gene editing passes test in monkeys

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Microsoft's Peter Lee: Generative AI could help doctors be more human

Lung cancer screening guidelines updated for cigarette smokers

knowledge

focus

hotspot

hotspot